ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

Published 2018 View Full Article

Authors

Keywords

Journal

CLINICAL MICROBIOLOGY AND INFECTION

Volume 24, Issue -, Pages S83-S94

Publisher

Elsevier BV

Online

2018-03-21

DOI

10.1016/j.cmi.2018.03.022

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CLINICAL MICROBIOLOGY AND INFECTION

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Become a Peeref-certified reviewer

Ask a Question. Answer a Question.